🎧 #ChatsWithChaudhrey 𝐭𝐡𝐞 𝐏𝐨𝐝𝐜𝐚𝐬𝐭 S6E05 #RF2526 S6E05 with CoJourney Founder and CEO Lijun Wang Feb 26 2026

I had the pleasure of sitting down with Lijun recently to get her thoughts on what's been happening in  the Cell and Gene space over the past year and looking ahead to this year, we also talked about the differences between Cell and Gene therapy in China and the US.

I asked Lijun....

 ◉ 00:50 Hi Lijun, can you give viewers a quick introduction to CoJourney and your role and background?

 𝐑𝐞𝐟𝐥𝐞𝐜𝐭𝐢𝐨𝐧𝐬 2025

 ◉ 02:09  How would you describe 2025 in one word

◉ 03:47 How was 2025 for CoJourney and what were some of your highlights?

◉ 06:05 What do you think were some of the challenges the #CellandGeneTherapy faced last year and how did the sector overcome them?

◉ 09:48 What trends did you see emerge in 2025? 

◉ 12:20 As a company with a footprint in both China and North America, how would you compare the two markets in terms of the #CGT space and what would you say are the main differences between them?

◉ 14:38 What impact, if any has the Biosecure Act had on the two markets to date?

 𝐅𝐨𝐫𝐞𝐜𝐚𝐬𝐭𝐬 2026

 ◉ 16:45 Following in from the last question, looking ahead to 2026, and I know you were at JP Morgan earlier this year, how do you think the markets will behave this year?

◉ 20:45 What trends should we be looking out for in the CGT space in 2026?

◉ 24:11 What can we expect to see from CoJourney this year?

🎞 Watch the interview here https://lnkd.in/eKb5GzSj

You can meet Lijun and the CoJourney at ELRIG Cell and Gene Therapy event on 9th and 10th March in Hixton near Cambridge (The UK one!) as well as many other events globally.

See you there!

#RSKCoJourney #RSKCGT  #CGT #CELLandGeneTherapy